Lyra Therapeutics, Inc. (LYRA)
1.89
-0.10
(-5.03%)
USD |
NASDAQ |
Jan 14, 16:00
1.90
+0.01
(+0.53%)
Pre-Market: 20:00
Lyra Therapeutics Total Liabilities (Quarterly): 48.04M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Dentsply Sirona, Inc. | 4.175B |
| Perspective Therapeutics, Inc. | 52.61M |
| Electromed, Inc. | 8.869M |
| InfuSystem Holdings, Inc. | 43.41M |
| Xtant Medical Holdings, Inc. | 55.94M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 43.71M |
| Shareholders Equity (Quarterly) | -4.328M |
| Debt to Equity Ratio | -7.250 |
| Current Ratio | 2.428 |
| Net Debt Paydown Yield | 12.42% |